Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Blunt

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Age and Ageing|February 26, 2000
Measuring symptom change in patients with Parkinson's diseaseJ E Harrison, S Preston, S B Blunt
Experimental Brain Research|January 1, 1992
Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopaS B Blunt, P Jenner, C D Marsden
Neuroscience|January 1, 1991
The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiographyS B Blunt, P Jenner, C D Marsden
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Steroid-responsive chorea in childhood following cardiac transplantationS B Blunt, D J Brooks, C Kennard
Brain Research|November 14, 1998
Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatumJ Opacka-Juffry, A W Wilson, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesionsK P Datla, S B Blunt, D T Dexter
Archives of Neurology|March 1, 1993
Babinski yes, Hachinski noG N Fuller, S B Blunt, M T Silva
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Facial myokymia in multiple system atrophyS B Blunt, N M Khalil, G D Perkin
The European Journal of Neuroscience|September 30, 1998
Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivoA M Sullivan, J Opacka-Juffry, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Orolingual dystonia with "tip of the tongue" gesteS B Blunt, G Fuller, C Kennard, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Age and Ageing|February 26, 2000
Measuring symptom change in patients with Parkinson's diseaseJ E Harrison, S Preston, S B Blunt
Experimental Brain Research|January 1, 1992
Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopaS B Blunt, P Jenner, C D Marsden
Neuroscience|January 1, 1991
The effect of L-dopa and carbidopa treatment on the survival of rat fetal dopamine grafts assessed by tyrosine hydroxylase immunohistochemistry and [3H]mazindol autoradiographyS B Blunt, P Jenner, C D Marsden
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1994
Steroid-responsive chorea in childhood following cardiac transplantationS B Blunt, D J Brooks, C Kennard
Brain Research|November 14, 1998
Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatumJ Opacka-Juffry, A W Wilson, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|June 8, 2001
Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl(3) nigrostriatal lesionsK P Datla, S B Blunt, D T Dexter
Archives of Neurology|March 1, 1993
Babinski yes, Hachinski noG N Fuller, S B Blunt, M T Silva
Movement Disorders : Official Journal of the Movement Disorder Society|March 1, 1997
Facial myokymia in multiple system atrophyS B Blunt, N M Khalil, G D Perkin
The European Journal of Neuroscience|September 30, 1998
Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivoA M Sullivan, J Opacka-Juffry, S B Blunt
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1994
Orolingual dystonia with "tip of the tongue" gesteS B Blunt, G Fuller, C Kennard, et al.
Pageof 3